Representative dot-plots illustrate the comparison of CD14++CD16- classical monocytes expressing IFN-alpha in blood samples treated with polyclonal stimuli from participants who developed mild or severe COVID-19 during the follow-up (Figure 4A). This evidence concerns the gene CD14 and COVID-19.